l-carnitine a nutrient in red meat promotes atherosclerosis Revisiting the Role of Carnitine Heart Disease Through the Lens of the Gut Microbiota Intestinal microbiota metabolism of L-carnitine,

Previous clinical trials with different pharmacological agents with strong evidence for benefit in HFrEF such as angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and digoxin have all failed to show significant benefit in the treatment of HFpEF [57-62]

and differing blood collection time points

Research suggests that VLEKT has therapeutic potential in treating HS symptoms, particularly through its anti-inflammatory effects, reduction of body fat, and changes in the gut microbiota composition, which modulate systemic inflammation and oxidative stress (216)

Manfridi A, Forloni GL, Arrigoni-Martelli E, Mancia M

[DOI] [PubMed] [Google Scholar] 155.Vaezi Z, Amini A

In these cases, an excess of TMA-producing gut bacteria overwhelms even a functional FMO3 enzyme